Advanced Search

    Technical Analysis for MYNZ - Mainz Biomed B.V.

    Grade Last Price % Change Price Change
    D 6.22 -4.01% -0.26
    MYNZ closed down 4.01 percent on Wednesday, March 22, 2023, on 80 percent of normal volume.
    Earnings due: Apr 11
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical MYNZ trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction -4.01%
    NR7 Range Contraction -4.01%
    Gapped Up Strength -4.01%
    New 52 Week Closing Low Bearish 1.80%
    Lower Bollinger Band Walk Weakness 1.80%
    Below Lower BB Weakness 1.80%
    Gapped Down Weakness 1.80%
    Lower Bollinger Band Touch Weakness 1.80%
    Calm After Storm Range Contraction -5.47%
    Lower Bollinger Band Walk Weakness -5.47%
    Older End-of-Day Signals for MYNZ ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    10 DMA Resistance about 13 hours ago
    Down 3% about 13 hours ago
    Fell Below Previous Day's Low about 13 hours ago
    Down 2 % about 13 hours ago
    Down 1% about 13 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators Basic chart:

    Profile

    Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic tests for clinical diagnostics in the area of human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, an early-stage molecular lateral-flow test; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Cancer Clinical Medicine Medical Genetics Medical Test Pancreatic Cancer Colorectal Cancer Diagnostic Tests Molecular Diagnostics Cancer Screening Innogenetics

    Is MYNZ a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 15 Mainz teams up with Labor Staber to market colorectal cancer test ColoAlert in Germany
    Mar 15 Mainz Biomed Announces Partnership with Labor Staber to Expand ColoAlert Commercialization in Germany
    Mar 8 Mainz Biomed Launches Number of Educational Events in Germany to Raise Awareness for CRC Screening and Early Detection
    Mar 1 Mainz Biomed Recognizes Colorectal Cancer Awareness Month Throughout “Blue” March 2023
    Feb 28 Mainz Biomed to Appear on ClearThink IR’s Virtual Live Event on Wednesday, March 1, 2023 at 12 Noon ET
    Feb 21 Mainz stock rises on acquiring IP for colorectal cancer detection test ColoAlert
    Feb 21 Mainz Biomed Acquires Entire Intellectual Property Portfolio for its Colorectal Cancer Diagnostic Test Program
    Feb 15 Mainz Biomed enters commercial partnerships for ColoAlert with two independent laboratories
    Feb 15 Mainz Biomed Expands European Commercial Footprint and Enters Markets in Spain and UK
    Jan 18 Mainz Biomed Launches Corporate Health Program in Germany for ColoAlert
    See more MYNZ news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 15.94
    52 Week Low 5.42
    Average Volume 33,679
    200-Day Moving Average 8.05
    50-Day Moving Average 6.77
    20-Day Moving Average 6.71
    10-Day Moving Average 6.46
    Average True Range 0.43
    RSI 40.48
    ADX 22.63
    +DI 16.57
    -DI 27.10
    Chandelier Exit (Long, 3 ATRs) 6.20
    Chandelier Exit (Short, 3 ATRs) 6.71
    Upper Bollinger Bands 7.31
    Lower Bollinger Band 6.11
    Percent B (%b) 0.09
    BandWidth 17.81
    MACD Line -0.15
    MACD Signal Line -0.10
    MACD Histogram -0.0536
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 6.76
    Resistance 3 (R3) 6.81 6.69 6.67
    Resistance 2 (R2) 6.69 6.55 6.66 6.64
    Resistance 1 (R1) 6.45 6.46 6.39 6.40 6.61
    Pivot Point 6.33 6.33 6.30 6.30 6.33
    Support 1 (S1) 6.09 6.19 6.03 6.04 5.83
    Support 2 (S2) 5.97 6.10 5.94 5.80
    Support 3 (S3) 5.73 5.97 5.77
    Support 4 (S4) 5.68